About QuidelOrtho
QuidelOrtho is a publicly listed company based in San Diego (United States) founded in 1937. Provider of healthcare information services. The company has 6,600 employees. Its chief executive, as recorded, is Douglas Bryant. Its website quidelortho.com draws about 75 thousand monthly visits. QuidelOrtho offers products and services including QuickVue COVID-19 Test, Sofia Platform, and Solana Molecular Testing Platform. Its focus areas include Diversified Diagnostics. Its legal entity is QuidelOrtho Corporation.
Company details
QuidelOrtho, backed by 73950786.456085 from European Union, HHS, Algert Global, focuses on providing healthcare solutions, and diversified diagnostics. Provider of healthcare information services. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
- Annual Revenue$2.73 B (USD)-2.1as on Dec 31, 2025
- Net Profit-$1.13 B (USD)44.84as on Dec 31, 2025
- EBITDA$493.8 M (USD)-1.63as on Dec 31, 2025
- Latest Funding Round$20.69K (USD), Grant
Dec 2021
- InvestorsHHS
& 2 more
- Employee Count6,600
Associated legal entities of QuidelOrtho
QuidelOrtho is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ortho Clinical Diagnostics India Private Limited CIN U51397MH2015FTC262650 | Active | 12 Mar 2015 | Mumbai, Maharashtra | ₹965 Cr | 237 | 5 | View details |
| Quidel Diagnostics India Private Limited CIN U74999MH2019FTC321946 | Under Liquidation | 27 Feb 2019 | Mumbai, Maharashtra | ₹8.9 Cr | 2 | View details |
Products & Services of QuidelOrtho
QuidelOrtho offers a comprehensive portfolio of products and services, including QuickVue COVID-19 Test, Sofia Platform, and Solana Molecular Testing Platform.
Fast lateral-flow test for detecting COVID-19 at home
Benchtop system for rapid diagnostic testing
Platform for faster molecular assays in labs
Apps and channels of QuidelOrtho
QuidelOrtho publishes 1 mobile app; its YouTube channel QuidelOrtho has 235 subscribers and 30 videos.
Videos from QuidelOrtho
The most watched videos on QuidelOrtho's YouTube channel, QuidelOrtho (235 subscribers). Click a video to play it here.
More on QuidelOrtho.
Funding Insights of QuidelOrtho
- Total Rounds 15
- Last Round Grant — $20,692
- First Round $805,716
(Sep 2008)
- Investors Count 3
Latest 10 of 15 funding rounds of QuidelOrtho with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $20,692 | Grant | – | – | |
| Oct 2021 | $15,129 | Grant | – | – | |
| Oct 2021 | $3,579 | Grant | – | – | |
| Sep 2021 | $19,399 | Grant | – | – | |
| Sep 2021 | $17,955 | Grant | – | – | |
| Jun 2020 | $634,643 | Grant | – | – | |
| Mar 2020 | $117,352 | Grant | – | – | |
| Jun 2019 | Unspecified | – | – | – | |
| Aug 2018 | $40,391 | Grant | – | – | |
| Mar 2018 | $68M | Unspecified | – | – | – |
3 investors in total: 3 institutional.
Investors in QuidelOrtho
QuidelOrtho has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, European Union and Algert Global.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Systematic equity investment firm managing capital for institutional investors globally. | 2002 | algertglobal.com | San Francisco, United States |
Investor details for QuidelOrtho
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of QuidelOrtho
The boards of the 2 registered companies of QuidelOrtho currently have 6 directors; the longest-serving is Anand Pande, appointed in 2015. 19 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anand Pande DIN 07326192 | Director | 05 Nov 2015 | 10 yrs 11 mo | Ortho Clinical Diagnostics India Private Limited |
| Maheshwar Sadashiv Wagle DIN 08860885 | Director | 10 Sep 2020 | 6 yrs 1 mo | Ortho Clinical Diagnostics India Private Limited |
| Joseph Michael Busky DIN 08297588 | Director | 16 Oct 2020 | 6 yrs | Ortho Clinical Diagnostics India Private Limited |
| Deep Omprakash Shukla DIN 03030194 | Additional Director | 18 Oct 2024 | 2 yrs | Quidel Diagnostics India Private Limited |
| Syed Mohammad Rafeeq DIN 10862254 | Director | 04 Dec 2024 | 1 yr 11 mo | Ortho Clinical Diagnostics India Private Limited |
| Sandeep Chimaji Kadam DIN 02654725 | Additional Director | 10 Dec 2024 | 1 yr 10 mo | Quidel Diagnostics India Private Limited |
People of QuidelOrtho
615 people are tracked at QuidelOrtho (149 in leadership, 12 in board & advisors, 454 in team); the tracked headcount is 6,600.
| Name | Role | Group |
|---|---|---|
Douglas Bryant | CEO | Leadership |
Ken Dryden | Senior Director, Global Facilities | Leadership |
Deanna Dietl | Senior Director, People & Culture (global Manufacturing, Supply Chain, Quality & R&d) | Leadership |
Isabelle Lefevre | Head Of Marketing France | Leadership |
Courtney K | Molecular Enterprise Director | Leadership |
Andy Pal | Director - Software Engineering Instrument Systems | Leadership |
Alastair Manning | Commercial Cluster Director North West Europe | Leadership |
Danielle Hamann | Vice President Finance | Leadership |
Scott MacPherson | Global Head, Transfusion Medicine Product Management & Marketing | Leadership |
Krissie Marsh | Regional Sales Director | Leadership |
Kassady Smith | Associate Human Resources Business Partner | Leadership |
Beatrice Avalos | Associate Director, R&d | Leadership |
Katy Marcum | Global Head, Clinical Labs Business Unit | Leadership |
Adam Weinstein | Director, Transfusion Medicine Platforms | Leadership |
Samantha Fok Vahabzadeh | Associate Director, Accounting | Leadership |
Grayson Porter | Head Of Strategic Markets | Leadership |
Rafeeq S M | Country Director- India & Saarc | Leadership |
Alessia Mineo | HR Business Partner & Ta, Italy | Leadership |
Rebecca H. | Senior People & Culture Business Partner | Leadership |
Jonathan Siegrist | EVP, Research & Development & CTO | Leadership |
595 more people are available in the full profile.
Complete people profiles for QuidelOrtho
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of QuidelOrtho
QuidelOrtho is a publicly listed company on the NASDAQ with ticker symbol QDEL in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date28 Jan 2021
- Listed onNASDAQ: OCDX
- Listed entityQuidelOrtho Corporation
- Exchange sectorHealth technology
- ISINUS2197981051
- Share price$14.10 (+6.42% on the day) · 2026-10-13
- Market capitalisation$966.9M
- EPS (diluted, trailing year)$-15.41
- Volume (last session)3,053,267
Financials of QuidelOrtho
Figures of Ortho Clinical Diagnostics India Private Limited, the primary company behind QuidelOrtho, for FY 2025. Revenue was ₹965 Cr (+24% year on year). Net profit was ₹23.40 Cr (2% margin). EBITDA was ₹141 Cr (15% margin). Revenue has grown at a compounded annual rate of +18% over three years and +16% over five years.
- ₹965 CrRevenue · FY 2025 · +24% YoY
- ₹23.40 CrNet profit · 2% margin
- ₹141 CrEBITDA · 15% margin
- ₹99.56 CrPaid-up capital
- 237Employees (provident fund records)
- +18%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $2.73B | -$1.13B | $493.8M |
| 2024 | $2.79B | -$2.05B | $502.0M |
| 2023 | $2.99B | -$10.1M | $703.5M |
| 2022 | $3.26B | $548.7M | $1.26B |
| 2021 | $1.70B | $704.2M | $970.2M |
Balance sheet, profit and loss, cash flow and ratios of Ortho Clinical Diagnostics India Private Limited are on its company page.
Detailed financial statements for QuidelOrtho
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of QuidelOrtho
4 dated milestones of QuidelOrtho across 84 years, from founding to its latest funding, stage changes and deals.
- Founded QuidelOrtho is founded.
- Funding First funding round of $806K.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Grant, of $21K.
Web traffic of QuidelOrtho
The website of QuidelOrtho (quidelortho.com) receives about 74.5K visits a month and ranks #430,293 among all websites worldwide, #6,574 in Jobs and Career.
- Monthly visits74.5K
▲ 2.4% vs previous month
- Unique visitors26K
per month
- Global rank#430,293
among all websites
- Category rank#6,574
Jobs and Career · Jobs and Career
- Bounce rate32%
- Pages per visit3.2
- Average visit1 min 20 sec
- DevicesDesktop 53% · Mobile 47%
Top companies in Diagnostics & Lab Tech
3 companies that operate in the same segment as QuidelOrtho (Diagnostics & Lab Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
At-home health tests for biomarkers, nutrition, and hormone analysis. | 2014 | Austin, Texas, United States | USD 330 M | 336 | ||
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | |||
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | USD 4.45 M | 54 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Quidelortho
Complete news archive for QuidelOrtho
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about QuidelOrtho
QuidelOrtho was founded in 1937 and raised its 1st funding round 71 years after it was founded.
QuidelOrtho is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Douglas Bryant is the CEO of QuidelOrtho, as recorded in our data.
QuidelOrtho has 6,600 employees.
Annual revenue of QuidelOrtho is $2.73B as on Dec 31, 2025.
QuidelOrtho, backed by 73950786.456085 from European Union, HHS, Algert Global, focuses on providing healthcare solutions, and diversified diagnostics. Provider of healthcare information services. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
QuidelOrtho offers QuickVue COVID-19 Test, Sofia Platform, and Solana Molecular Testing Platform.
Yes, QuidelOrtho is publicly traded on NASDAQ under the ticker symbol QDEL.
QuidelOrtho has 3 investors. Key investors include HHS, European Union, and Algert Global.
QuidelOrtho is associated with 2 legal entities: Ortho Clinical Diagnostics India Private Limited, Quidel Diagnostics India Private Limited.
The legal entities of QuidelOrtho currently have 7 directors, including Maheshwar Sadashiv Wagle, Anand Pande, Kajal Jayant Mehta and others.
Yes. QuidelOrtho publishes QVue.